David J. Rosa

David J. Rosa is president, leading Intuitive’s core business and driving product and commercial excellence, and a member of the Board of Directors. Rosa has been a passionate supporter and evangelist of da Vinci technology since its inception.

Rosa joined Intuitive in March 1996 and has held leadership positions in engineering, clinical development, marketing, and product development. In April 2011, Rosa was promoted to the position of senior vice president, emerging procedures and technology, and transitioned to the position of senior vice president, scientific affairs. In August 2014, Rosa was promoted to the position of executive vice president and chief scientific officer. In June 2015, Rosa was appointed as executive vice president and chief commercial officer. In January 2019, he took on additional responsibility as executive vice president and chief business officer. In January 2022, Rosa transitioned to chief strategy and growth officer. In May 2023, Rosa was promoted to the role of president of the company. In July 2024, he was appointed to the Board of Directors.

Prior to Intuitive, Rosa contributed to the development of trans-esophageal transducers for Acuson Corporation. He serves on the board of directors’ compensation committee for Kardium, a private company based in Vancouver, Canada, that focuses on the treatment of atrial fibrillation. Rosa also serves as chairman of the board of the joint venture between Intuitive Surgical and Fosun Pharma based in Shanghai, China.

A holder of multiple patents, Rosa earned a BS in mechanical engineering from California Polytechnic University at San Luis Obispo and an MS in mechanical engineering from Stanford University.